Clinical Trial Update: Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes

View source ↗

Summary

Clinical trial update detailing management strategies and outcomes from Trifecta and Epic ViV studies in patients with aortic valve disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• Epic ViV
• Trifecta Valve

Snippet

Sponsor: Helios Health Institute GmbH | Conditions: Aortic Valve Disease | Status: COMPLETED